IPR Ethical Issues, Biopiracy, TKDL & Role of IPR in Startups | MSc Microbiology Unit 5 Part 2 | UOK

Msc Microbiology 4 sem unit 5 Part 2 In the fields of biology and biotechnology, the management of Intellectual Property Rights (IPR) involves a delicate balance between fostering commercial innovation and addressing profound ethical concerns regarding life forms and genetic resources. 1. Ethical Issues in IPR for Biology The sources highlight several critical ethical dilemmas that arise when granting property rights over biological innovations and genetic resources. Human Morality and Public Order: Under Indian law, inventions that are contrary to public morality are excluded from patent protection. Specifically, the cloning of human embryos and the creation of super microbial pathogens that could "play havoc with human lives" are strictly banned from IPR registration. Biopiracy and Resource Piracy: This occurs when biological or natural resources (such as Turmeric, Neem, or Basmati rice) are taken from their home country and patented elsewhere without prior permission or recognition. These resources often draw upon Traditional Knowledge (TK) held by indigenous communities for generations. To combat this, India created the Traditional Knowledge Digital Library (TKDL) to provide prior art evidence and successfully revoke illegitimate foreign patents. Public Health vs. Monopoly Rights: A primary ethical concern is restricted access to life-saving medicines. While patents provide incentives for drug development, high costs can make treatments inaccessible. The Doha Declaration (2001) clarified that TRIPS should not prevent members from protecting public health, allowing for compulsory licensing during national emergencies to ensure society's demands for drugs and vaccinations are met. Farmers’ Rights vs. Corporate Control: Rigid IPR standards can negatively impact progress if they prevent farmers from storing seeds for the next crop or allow multinational companies to regulate seed prices beyond the reach of local communities. The PPV&FR Act, 2001 was enacted in India to balance these interests by granting farmers specific rights to save, use, and exchange seeds. Equitable Benefit Sharing: The Biological Diversity Act, 2002 requires that any party seeking access to India's genetic resources must obtain prior informed consent and agree to a fair and equitable sharing of benefits (monetary or non-monetary) arising from the commercial use of that knowledge or resource. 2. Role of IPR in Entrepreneurship and Start-ups For biology-based start-ups, IPR is often the most valuable asset, serving as the foundation for business growth and investment. IP as a Strategic Business Tool: In the modern knowledge-driven economy, IP rights are frequently more valuable than physical assets. For example, the IP produced by companies like Microsoft or Yahoo is valued higher than the tangible infrastructure of traditional industrial giants. Facilitating Investment and Funding: A strong IP portfolio makes "good business sense" by helping start-ups secure loans, enhance market image, and attract venture capital. It signals to investors that the company's innovations are protected from being "copied or closely imitated" by rivals. Government Support (SIPP Scheme): The Indian government launched the Scheme for Facilitating Start-ups Intellectual Property Protection (SIPP) to nurture and mentor emerging technologies. Under this scheme, start-ups can access high-quality IP services and receive assistance in filing patents, trademarks, and designs by paying only statutory fees. Support from NRDC: The National Research Development Corporation (NRDC) provides pro-bono advisory services to budding entrepreneurs, assisting with prior art searches, drafting specifications, and contesting oppositions. Technology Transfer and Licensing: For bio-entrepreneurs who may lack manufacturing facilities, IPR allows them to license their technology to established industries in exchange for royalties. This provides a lucrative revenue stream; it is noted that some individual inventors have made over $500 million through patent licensing without directly manufacturing products. Building Brand Identity: Beyond technical patents, start-ups use trademarks and industrial designs to distinguish their products in the open market and build consumer loyalty, which is referred to as "goodwill".